Sickle Cell Transition – Providers’ experience and the patients’ voice

Presented by:
Thomas Harrington, MD
University of Miami

Faculty Disclosure: Tom Harrington, MD has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: All relevant financial relationships have been mitigated.

Release Date: April 1, 2022
Expiration Date: March 31, 2023

Target Audience: Primary Care Physicians, Specialty Physicians, Physician Assistants, Nurses, Pharmacists

Learning Objectives:
As a result of participation in this activity, participants should be able to:

  • Learn critical issues that can hinder successful transition
  • See need to expand primary care and other sub-specialty providers to handle adults with sickle cell
  • Understand the role of psychological issues and perceived stigma play in adult care.

Requirements for successful completion: Certificates are awarded upon successful completion (80% proficiency) of the post-test.

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resource(s) for further study:

  • Ara and Brown; American Journal of Public Health Research. 2021; 9(5):222-228
  • Lanzkron., et al: J Clin Transl Sci. 2018 Oct; 2(5): 334-342.



For additional information, contact Debbie Ringdahl at 352-273-9120 or e-mail